Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Active implantable device vulnerability to interference from theft detection systems probed by FDA.

This article was originally published in The Gray Sheet

Executive Summary

ACTIVE IMPLANTS' VULNERABILITY TO RETAIL STORE SECURITY SYSTEM INTERFERENCE is being investigated by FDA. The agency is asking manufacturers of electronic article surveillance (EAS) systems to submit data to help it determine if the systems, which are commonly found in retail stores, pose a risk of electromagnetic interference with pacemakers, implantable cardioverter defibrillators, and other active implantable medical devices.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008999

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel